Chugai Pharmaceutical : Atea Announces Update on Collaboration with Roche for AT-527
11/16/2021 | 10:17pm EST
Atea Announces Update on Collaboration with Roche for AT-527
TOKYO, November 17, 2021 --Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced that Atea issued a press release on its collaboration with Roche for the investigational oral COVID-19 treatment AT- 527.
Chugai Pharmaceutical Co. Ltd. published this content on 17 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2021 03:16:07 UTC.